Institutional investors hold a majority ownership of IMGN through the 91.79% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2015, these large investors purchased a net $2.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DANSKE BANK A/S (INVT MGMT) Bought 1.6 Thousand shares of ImmunoGen Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 170.00 shares of ImmunoGen Inc
QS BATTERYMARCH FINANCIAL MANAGE... Bought 149.00 shares of ImmunoGen Inc